194 related articles for article (PubMed ID: 32629160)
21. Matrigel Mattress: A Method for the Generation of Single Contracting Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
Feaster TK; Cadar AG; Wang L; Williams CH; Chun YW; Hempel JE; Bloodworth N; Merryman WD; Lim CC; Wu JC; Knollmann BC; Hong CC
Circ Res; 2015 Dec; 117(12):995-1000. PubMed ID: 26429802
[TBL] [Abstract][Full Text] [Related]
22. Functional cardiotoxicity assessment of cosmetic compounds using human-induced pluripotent stem cell-derived cardiomyocytes.
Chaudhari U; Nemade H; Sureshkumar P; Vinken M; Ates G; Rogiers V; Hescheler J; Hengstler JG; Sachinidis A
Arch Toxicol; 2018 Jan; 92(1):371-381. PubMed ID: 28940058
[TBL] [Abstract][Full Text] [Related]
23. Chronic Cardiotoxicity Assays Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes (hiPSC-CMs).
Narkar A; Willard JM; Blinova K
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328619
[TBL] [Abstract][Full Text] [Related]
24. Dasatinib can Impair Left Ventricular Mechanical Function But May Lack Proarrhythmic Effect: A Proposal of Non-clinical Guidance for Predicting Clinical Cardiovascular Adverse Events of Tyrosine Kinase Inhibitors.
Izumi-Nakaseko H; Fujiyoshi M; Hagiwara-Nagasawa M; Goto A; Chiba K; Kambayashi R; Naito AT; Ando K; Kanda Y; Ishii I; Sugiyama A
Cardiovasc Toxicol; 2020 Feb; 20(1):58-70. PubMed ID: 31280457
[TBL] [Abstract][Full Text] [Related]
25. Y-27632 preconditioning enhances transplantation of human-induced pluripotent stem cell-derived cardiomyocytes in myocardial infarction mice.
Zhao M; Fan C; Ernst PJ; Tang Y; Zhu H; Mattapally S; Oduk Y; Borovjagin AV; Zhou L; Zhang J; Zhu W
Cardiovasc Res; 2019 Feb; 115(2):343-356. PubMed ID: 30107391
[TBL] [Abstract][Full Text] [Related]
26. Hybrid Cell Analysis System to Assess Structural and Contractile Changes of Human iPSC-Derived Cardiomyocytes for Preclinical Cardiac Risk Evaluation.
Lickiss B; Gossmann M; Linder P; Thomas U; Dragicevic E; Lemme M; George M; Fertig N; Stölzle-Feix S
J Vis Exp; 2022 Oct; (188):. PubMed ID: 36342136
[TBL] [Abstract][Full Text] [Related]
27. Functional and Transcriptional Characterization of Histone Deacetylase Inhibitor-Mediated Cardiac Adverse Effects in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
Kopljar I; Gallacher DJ; De Bondt A; Cougnaud L; Vlaminckx E; Van den Wyngaert I; Lu HR
Stem Cells Transl Med; 2016 May; 5(5):602-12. PubMed ID: 27034410
[TBL] [Abstract][Full Text] [Related]
28. A mathematical model of hiPSC cardiomyocytes electromechanics.
Forouzandehmehr M; Koivumäki JT; Hyttinen J; Paci M
Physiol Rep; 2021 Nov; 9(22):e15124. PubMed ID: 34825519
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of chronic drug-induced electrophysiological and cytotoxic effects using human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs).
Altrocchi C; Van Ammel K; Steemans M; Kreir M; Tekle F; Teisman A; Gallacher DJ; Lu HR
Front Pharmacol; 2023; 14():1229960. PubMed ID: 37492082
[No Abstract] [Full Text] [Related]
30. Contractility assessment of human iPSC-derived cardiomyocytes by using a motion vector system and measuring cell impedance.
Satsuka A; Hayashi S; Yanagida S; Ono A; Kanda Y
J Pharmacol Toxicol Methods; 2022; 118():107227. PubMed ID: 36243255
[TBL] [Abstract][Full Text] [Related]
31. hiPSC-CM electrophysiology: impact of temporal changes and study parameters on experimental reproducibility.
Guerrelli D; Pressman J; Salameh S; Posnack N
Am J Physiol Heart Circ Physiol; 2024 Jul; 327(1):H12-H27. PubMed ID: 38727253
[TBL] [Abstract][Full Text] [Related]
32. Cardiac safety assessment with motion field imaging analysis of human iPS cell-derived cardiomyocytes is improved by an integrated evaluation with cardiac ion channel profiling.
Isobe T; Honda M; Komatsu R; Tabo M
J Toxicol Sci; 2019; 44(12):859-870. PubMed ID: 31813905
[TBL] [Abstract][Full Text] [Related]
33. Development of In Vitro Drug-Induced Cardiotoxicity Assay by Using Three-Dimensional Cardiac Tissues Derived from Human Induced Pluripotent Stem Cells.
Takeda M; Miyagawa S; Fukushima S; Saito A; Ito E; Harada A; Matsuura R; Iseoka H; Sougawa N; Mochizuki-Oda N; Matsusaki M; Akashi M; Sawa Y
Tissue Eng Part C Methods; 2018 Jan; 24(1):56-67. PubMed ID: 28967302
[TBL] [Abstract][Full Text] [Related]
34. Development of torsadogenic risk assessment using human induced pluripotent stem cell-derived cardiomyocytes: Japan iPS Cardiac Safety Assessment (JiCSA) update.
Kanda Y; Yamazaki D; Osada T; Yoshinaga T; Sawada K
J Pharmacol Sci; 2018 Dec; 138(4):233-239. PubMed ID: 30415824
[TBL] [Abstract][Full Text] [Related]
35. Detection of Drug-Induced Torsades de Pointes Arrhythmia Mechanisms Using hiPSC-CM Syncytial Monolayers in a High-Throughput Screening Voltage Sensitive Dye Assay.
da Rocha AM; Creech J; Thonn E; Mironov S; Herron TJ
Toxicol Sci; 2020 Feb; 173(2):402-415. PubMed ID: 31764978
[TBL] [Abstract][Full Text] [Related]
36. From the Cover: High-Throughput Imaging of Cardiac Microtissues for the Assessment of Cardiac Contraction during Drug Discovery.
Pointon A; Pilling J; Dorval T; Wang Y; Archer C; Pollard C
Toxicol Sci; 2017 Feb; 155(2):444-457. PubMed ID: 28069985
[TBL] [Abstract][Full Text] [Related]
37. Use of Human iPSC-CMs in Nonclinical Regulatory Studies for Cardiac Safety Assessment.
Yang X; Ribeiro AJS; Pang L; Strauss DG
Toxicol Sci; 2022 Nov; 190(2):117-126. PubMed ID: 36099065
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of nefazodone-induced cardiotoxicity in human induced pluripotent stem cell-derived cardiomyocytes.
Lee S; Lee HA; Choi SW; Kim SJ; Kim KS
Toxicol Appl Pharmacol; 2016 Apr; 296():42-53. PubMed ID: 26821276
[TBL] [Abstract][Full Text] [Related]
39. Tracking single hiPSC-derived cardiomyocyte contractile function using CONTRAX an efficient pipeline for traction force measurement.
Pardon G; Vander Roest AS; Chirikian O; Birnbaum F; Lewis H; Castillo EA; Wilson R; Denisin AK; Blair CA; Holbrook C; Koleckar K; Chang ACY; Blau HM; Pruitt BL
Nat Commun; 2024 Jun; 15(1):5427. PubMed ID: 38926342
[TBL] [Abstract][Full Text] [Related]
40. Development and validation of dual-cardiotoxicity evaluation method based on analysis of field potential and contractile force of human iPSC-derived cardiomyocytes / multielectrode assay platform.
Lee SG; Kim J; Oh MS; Ryu B; Kang KR; Baek J; Lee JM; Choi SO; Kim CY; Chung HM
Biochem Biophys Res Commun; 2021 May; 555():67-73. PubMed ID: 33813278
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
